Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05010603 · ClinicalTrials.gov registry record
Late Onset Alzheimer's Disease
A clinical trial of Alzheimer Disease, sponsored by Columbia University.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 12
- Study locations
NCT05010603: Recruiting study of Alzheimer Disease, sponsored by Columbia University.
NCT05010603 is a study of Alzheimer Disease that is actively recruiting participants, run by Columbia University. The registered enrollment target is 10,000 participants, above the 2,718-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (268% higher). The trial reports 12 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05010603, a study of Alzheimer Disease, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.
Primary Outcome
Genetic Linkage Analysis to Identify Genes Associated with the risk of Alzheimer's Disease: Identification of genes by performing genetic linkage analysis, in order to detect the chromosomal location of genes that may increase the risk of Alzheimer's disease.
Conditions Studied
Interventions
- GENETIC Blood Draw
- OTHER Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
Study Locations (12)
Indiana
- Indiana University - Bloomington
- NCRAD at Indiana University - Indianapolis
District of Columbia
- University of Washington - Washington D.C.
Florida
- University of Miami - Miami
Illinois
- Rush University - Aurora
Minnesota
- Mayo Clinic - Rochester
Missouri
- Joanne Norton - St Louis
New York
- Columbia University Irving Medical Center - New York
North Carolina
- North Carolina State University - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2016-11-15 |
| Est. Completion | 2027-04-30 |
What NCT05010603 shows while recruiting
NCT05010603 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,718-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (268% higher).
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Blood Draw is the first listed.
NCT05010603 lists 12 locations in 11 states (Indiana, District of Columbia, Florida).
Frequently Asked Questions
What is clinical trial NCT05010603 about?
NCT05010603 is a clinical study titled "Late Onset Alzheimer's Disease". The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to ...
What is the current status of trial NCT05010603?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2016-11-15. Estimated completion is 2027-04-30.
What conditions does trial NCT05010603 study?
This clinical trial studies the following conditions: Alzheimer Disease.
What interventions are being tested in trial NCT05010603?
The interventions under investigation include: Blood Draw (GENETIC), Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test (OTHER).
Who is sponsoring clinical trial NCT05010603?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05010603 being conducted?
This trial has 12 study locations across District of Columbia, Florida, Illinois, Indiana, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05010603's enrollment target sits among peer trials
10,000 10th of 306 higher than 294 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
RECRUITING · Phase 3
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
RECRUITING · Phase 4
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Cognitive Neurology Unit Clinical Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI